GI MAP

Overview

The Gastrointestinal Microbial Assay Plus (GI-MAP) offers a detailed analysis of microorganisms present in the gastrointestinal tract by examining DNA extracted from a stool sample using advanced quantitative polymerase chain reaction (qPCR) techniques. This approach provides a broad overview of various microbial populations, including bacteria, fungi, viruses, and parasites, contributing to a better understanding of gut ecosystem diversity. The test combines microbial data with key digestive and immune markers such as calprotectin, secretory IgA, and pancreatic elastase, which can offer additional context regarding digestive health and immune responses.

By presenting quantitative results, the GI-MAP allows individuals and practitioners to observe changes in microbial patterns over time, which can support evaluations related to diet, lifestyle, or other wellness interventions. The information derived from this test helps in exploring potential influences on digestive comfort and overall wellbeing without focusing on specific clinical diagnoses. Supplementary analyses are available to expand insight into intestinal permeability markers like zonulin, as well as metabolic products such as bile acids and short-chain fatty acids through StoolOMX, plus gluten-related peptides to accommodate a broader interest in gut health factors.

Interpretation of the GI-MAP results is most meaningful when considered alongside personal lifestyle information and general health background, supporting a holistic perspective on digestive and immune system status. The test facilitates a greater understanding of how microbial balance might relate to general digestive wellness and other non-specific health parameters. This makes the GI-MAP a useful tool for those seeking knowledge about their gut microbiome and overall digestive environment for personal optimisation and lifestyle management.

Gastrointestinal Microbial Assay Plus (GI-MAP) is intended for informational, educational, wellness and/or research purposes only. It is not intended for use in medical diagnosis, disease screening or clinical decision-making. Gastrointestinal Microbial Assay Plus (GI-MAP) is not a replacement for clinical laboratory testing and does not provide medical diagnoses. This content is intended for general information within the EU market and should not be interpreted as a regulated in-vitro diagnostic claim.